| Title : Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods - Henstra_2022_Front.Psychiatry_13_953686 |
| Author(s) : Henstra MJ , Feenstra TC , Kok RM , Spaans HP , van Exel E , Dols A , Oudega M , Vergouwen ACM , van der Loo A , Bet PM , Loer SA , Eikelenboom M , Sienaert P , Lambrichts S , Bouckaert F , Bosmans JE , van der Velde N , Beekman ATF , Stek ML , Rhebergen D |
| Ref : Front Psychiatry , 13 :953686 , 2022 |
| Abstract : Henstra_2022_Front.Psychiatry_13_953686 |
| ESTHER : Henstra_2022_Front.Psychiatry_13_953686 |
| PubMedSearch : Henstra_2022_Front.Psychiatry_13_953686 |
| PubMedID: 35911242 |
| Title : Acetylcholinesterase inhibitors for electroconvulsive therapy-induced cognitive side effects: a systematic review - Henstra_2017_Int.J.Geriatr.Psychiatry_32_522 |
| Author(s) : Henstra MJ , Jansma EP , van der Velde N , Swart EL , Stek ML , Rhebergen D |
| Ref : Int J Geriatr Psychiatry , 32 :522 , 2017 |
| Abstract : Henstra_2017_Int.J.Geriatr.Psychiatry_32_522 |
| ESTHER : Henstra_2017_Int.J.Geriatr.Psychiatry_32_522 |
| PubMedSearch : Henstra_2017_Int.J.Geriatr.Psychiatry_32_522 |
| PubMedID: 28295591 |
| Title : Cognitive Impairment and Electroconvulsive Therapy in Geriatric Depression, What Could be the Role of Rivastigmine? A Case Series - van Schaik_2015_Clin.Pract_5_780 |
| Author(s) : van Schaik AM , Rhebergen D , Henstra MJ , Kadouch DJ , van Exel E , Stek ML |
| Ref : Clin Pract , 5 :780 , 2015 |
| Abstract : van Schaik_2015_Clin.Pract_5_780 |
| ESTHER : van Schaik_2015_Clin.Pract_5_780 |
| PubMedSearch : van Schaik_2015_Clin.Pract_5_780 |
| PubMedID: 26664715 |